Semaglutide continues to be demonstrated to trigger medullary thyroid mobile carcinoma in rodents. Though its medical relevance to people is unfamiliar, the FDA advises to not administer this drug in All those with a private or loved ones record of medullary thyroid carcinoma. Semaglutide also poses a danger of pancreatitis and dehydration.Jillian